表紙
市場調查報告書

核酸分離及純化的全球市場 - 成長,趨勢,預測(2019年∼2024年)

Nucleic Acid Isolation and Purification Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 661017
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
核酸分離及純化的全球市場 - 成長,趨勢,預測(2019年∼2024年) Nucleic Acid Isolation and Purification Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 112 Pages
簡介

全球核酸分離及純化市場成長,由於迅速的技術進步,診斷領域的核酸實驗的多樣用途,生物科技及醫療保健的研究開發資金的增加等而受到促進。

本報告提供全球核酸分離及純化市場調查,市場概要,各技術、產品、用途、終端用戶、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 迅速的技術進步
    • 診斷領域的核酸檢驗多樣的用途
    • 生物科技和醫療保健的研究開發資金的增加
  • 市場阻礙因素
    • 新興市場的滲透低
    • 自動設備的成本上升
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各技術
    • 管柱純化
    • 磁珠純化
    • 試劑純化
  • 各產品
    • 套件、試劑
    • 設備
    • 其他
  • 各用途
    • 總數RNA分離、純化
    • mRNA分離、純化
    • 微型核糖核酸分離、純化
    • 質體DNA分離、純化
    • 基因DNA分離、純化
    • 血液DNA分離、純化
    • PCR收拾乾淨
    • 其他
  • 各終端用戶
    • 醫院
    • 學術機構
    • 製藥、生物科技企業
    • 醫藥品開發受託機關(CRO)
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Agilent Technologies
    • Bio-Rad Laboratories Inc.
    • BioTek Instruments Inc.
    • BioVision Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare
    • Merck KGaA (Sigma-Aldrich Corporation)
    • Promega Corporation
    • Qiagen NV

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 50452

Market Overview

The growth of the nucleic acid isolation and purification market is due to the rapid technological advancements, wide-range applications of nucleic acid testing in diagnostics, and rise in the R&D funding in biotechnology and healthcare.

  • Nucleic acid has many diagnostic applications in tests of many diseases, such as STDs, congenital anomalies, cancer, etc.
  • According to the US Department of Health & Human Services, there were approximately 36.7 million people worldwide living with HIV/AIDS as of 2016. Of these, 2.1 million were children (<15 years old). The WHO stated that more than 1 million sexually transmitted infections are acquired every day worldwide and 500 million people are estimated to have genital infection with herpes simplex virus (HSV), along with 290 million women who have a human papillomavirus (HPV) infection. Therefore, all STDs can be diagnosed through nucleic acid isolation and identification procedures, and this signifies that the market studied is expected to increase globally.
  • The current market is also growing, due to rapid technological advancements, like polymerase chain reaction (the original nucleic acid amplification technique), which transformed the approach of the clinical microbiologists in viewing and using nucleic acid techniques in clinical settings.

Scope of the Report

As per the scope of the report, nucleic acid isolation and purification is a procedure in molecular biology techniques, such as cloning, sequencing, polymerase chain reaction, and other techniques. These techniques have various applications in the field of genetic engineering, life science research, forensics, and molecular diagnostics. The nucleic acid isolation helps in the processing of more sample in less time, minimizes nucleic acid loss degradation, and increases laboratory efficiency and effectiveness. It also helps in purification of nucleic acid.

Key Market Trends

The Equipment Segment is the Fastest Growing Segment and is Expected to Continue to Grow in the Forecast Period

The equipment segment of the market studied is growing at a good pace. There are significant advancements found in the field of molecular diagnostics that have facilitated rapid and continued advancements in nucleic acid isolation and purification technologies, driven by the new knowledge provided by the mapping of genetic risk factors behind many diseases, where lifestyle has an important role to play. In addition, the growth in laboratory automation and decreasing changeability may lead to the growth of the equipment segment of the market studied.

US Nucleic Acid Isolation and Purification Market is the Largest in North America and is Expected to Follow the Same Trend Over the Forecast Period

The US Nucleic Acid Isolation and Purification Market are the largest in North America that is mainly due to the very high use of downstream processes in the country. The growth of the market is also attributed due to the rapid technological advances, wide-range applications of nucleic acid testing in diagnostics boosting the market, rise in the R&D funding in biotechnology and healthcare.

Competitive Landscape

Some of the recent market trends in the global nucleic acid isolation and purification market are new product development, mergers and acquisition, and partnerships. Agilent Technologies, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare, Promega Corporation, Qiagen NV, and Thermo Fisher Scientific Inc. are some of the major players in the nucleic acid isolation and purification market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Technological Advancements Boosting the Market Growth
    • 4.2.2 Wide-range Applications of Nucleic Acid Testing in Diagnostics Boosting the Market
    • 4.2.3 Rise in the R&D Funding in Biotechnology and Healthcare
  • 4.3 Market Restraints
    • 4.3.1 Low Penetration in the Emerging Markets
    • 4.3.2 Increasing Cost of Automated Instruments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Column-based Purification
    • 5.1.2 Magnetic Bead-based Purification
    • 5.1.3 Reagent-based Purification
  • 5.2 By Product
    • 5.2.1 Kits and Reagents
    • 5.2.2 Equipment
    • 5.2.3 Other Products
  • 5.3 By Application
    • 5.3.1 Total RNA Isolation and Purification
    • 5.3.2 mRNA Isolation and Purification
    • 5.3.3 microRNA Isolation and Purification
    • 5.3.4 Plasmid DNA Isolation and Purification
    • 5.3.5 Genomic DNA Isolation and Purification
    • 5.3.6 Blood DNA Isolation and Purification
    • 5.3.7 PCR Clean-up
    • 5.3.8 Other Nucleic Acid Isolation and Purification Applications
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Academia
    • 5.4.3 Pharmaceutical/Biotechnology Industry
    • 5.4.4 CRO
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 US
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 UK
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Bio-Rad Laboratories Inc.
    • 6.1.3 BioTek Instruments Inc.
    • 6.1.4 BioVision Inc.
    • 6.1.5 Danaher Corporation
    • 6.1.6 F. Hoffmann-La Roche Ltd
    • 6.1.7 GE Healthcare
    • 6.1.8 Merck KGaA (Sigma-Aldrich Corporation)
    • 6.1.9 Promega Corporation
    • 6.1.10 Qiagen NV

7 MARKET OPPORTUNITIES AND FUTURE TRENDS